Why Veru Stock Got Dented Today

03:36pm, Friday, 08'th Jul 2022 The Motley Fool
A short-seller published a new analysis that calls some of its clinical trial data into question.
VERU gains on the success of its late stage study evaluating the efficacy and safety of oral sabizabulin 9 mg for COVID-19.

Why Veru Stock Trounced the Market on Thursday

10:55pm, Thursday, 07'th Jul 2022 The Motley Fool
Several analysts reiterate their bullish outlook on the company.

Why Veru Stock Trounced the Market on Thursday

06:55pm, Thursday, 07'th Jul 2022
Several analysts reiterate their bullish outlook on the company.
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp. American
Despite recent investor skepticism, the Phase 3 COVID-19 results for Veru Inc's (NASDAQ: VERU) sabizabulin published in the New England Journal of Medicine "addressed most concerns," Jefferies wri
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on Wednesday. Allena Pharmaceuticals recently announced rescheduling of special

Coinbase, Moderna And 56 Biggest Movers From Yesterday

08:42am, Thursday, 07'th Jul 2022 Benzinga
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-ti
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time chang

Why Veru Stock Is Popping Today

03:43pm, Wednesday, 06'th Jul 2022 The Motley Fool
It just published great-looking data from a phase 3 clinical trial for its antiviral treatment for severe COVID-19.

VERU Stock Pops on Clinical Trial Update

12:41pm, Wednesday, 06'th Jul 2022
Veru (VERU) stock is on the move Wednesday after the company published results from its Phase 3 clinical trial of sabizabulin. The post VERU Stock Pops on Clinical Trial Update appeared first on Inves

Why Veru Stock Is Popping Today

11:43am, Wednesday, 06'th Jul 2022
It just published great-looking data from a phase 3 clinical trial for its antiviral treatment for severe COVID-19.

Why Veru Stock Is Soaring

11:39am, Wednesday, 06'th Jul 2022
Veru Inc (NASDAQ: VERU) shares are trading higher Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizab

Why Veru Stock Surged Today

07:06pm, Tuesday, 07'th Jun 2022
The biotech's experimental oral COVID-19 treatment could be a game changer.
Veru Inc (NASDAQ: VERU) has submitted an emergency use authorization (EUA) for sabizabulin application to FDA for COVID-19 treatment. The application covers moderate to severe hospitalized COVID-19
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE